CBLL (CeriBell) Pretax Margin % : -67.85% (As of Dec. 2024)

View and export this data going back to 2024. Start your Free Trial

What is CeriBell Pretax Margin %?

Pre-Tax margin is calculated as Pre-Tax Income divided by its Revenue. CeriBell's Pre-Tax Income for the three months ended in Dec. 2024 was $-12.58 Mil. CeriBell's Revenue for the three months ended in Dec. 2024 was $18.53 Mil. Therefore, CeriBell's pretax margin for the quarter that ended in Dec. 2024 was -67.85%.

The historical rank and industry rank for CeriBell's Pretax Margin % or its related term are showing as below:

CBLL' s Pretax Margin % Range Over the Past 10 Years
Min: -143.36 Med: -65.13 Max: -61.82
Current: -64.35

CBLL's Pretax Margin % is ranked worse than
74.73% of 819 companies
in the Medical Devices & Instruments industry
Industry Median: 0.57 vs CBLL: -64.35

CeriBell Pretax Margin % Historical Data

The historical data trend for CeriBell's Pretax Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

CeriBell Pretax Margin % Chart

CeriBell Annual Data

Trend

Dec22

Dec23

Dec24

Pretax Margin %

-143.36

-65.13

-61.82

CeriBell Quarterly Data
	Dec22	Sep23	Dec23	Jun24	Sep24	Dec24
Pretax Margin %	Get a 7-Day Free Trial			-60.75	-63.01	-	-60.58	-67.85

Competitive Comparison of CeriBell's Pretax Margin %

For the Medical Devices subindustry, CeriBell's Pretax Margin %, along with its competitors' market caps and Pretax Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

CeriBell's Pretax Margin % Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, CeriBell's Pretax Margin % distribution charts can be found below:

* The bar in red indicates where CeriBell's Pretax Margin % falls into.

Save Embed

;

Save Embed

;

CeriBell Pretax Margin % Calculation

Pretax margin - also known as pretax profit margin is the ratio of Pretax Income divided by net sales or Revenue, usually presented in percent.

CeriBell's Pretax Margin for the fiscal year that ended in Dec. 2024 is calculated as

Pretax Margin	=	Pre-Tax Income (A: Dec. 2024 )	/	Revenue (A: Dec. 2024 )
	=	-40.455	/	65.444
	=	-61.82 %

CeriBell's Pretax Margin for the quarter that ended in Dec. 2024 is calculated as

Pretax Margin	=	Pre-Tax Income (Q: Dec. 2024 )	/	Revenue (Q: Dec. 2024 )
	=	-12.576	/	18.534
	=	-67.85 %

CeriBell (NAS:CBLL) Pretax Margin % Explanation

The pretax margin, as know as pretax profit margin, is widely used to measure the operating efficiency of a company before deducting taxes.

The pretax margin is sometimes preferred over the net margin as tax expenditures can make profitability comparisons between companies misleading.

It is a useful tool to compare companies operating in the same sector and less effective when comparing companies from other sectors as each industry generally has different operating expenses and sales patterns.

The long term trend of the pretax margin is a good indicator of the competitiveness and health of the business.

CeriBell Pretax Margin % Related Terms

Thank you for viewing the detailed overview of CeriBell's Pretax Margin % provided by GuruFocus.com. Please click on the following links to see related term pages.

CeriBell Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » CeriBell Inc (NAS:CBLL) » Definitions » Pretax Margin %

Comparable Companies

Traded in Other Exchanges

N/A

Address

360 N. Pastoria Avenue, Sunnyvale, CA, USA, 94085

Website

https://www.ceribell.com

CeriBell Inc is a commercial-stage medical technology company focused on transforming the diagnosis and management of patients with serious neurological conditions. The Company has developed the Ceribell System, a novel, point-of-care electroencephalography (EEG) platform specifically designed to address the unmet needs of patients in the acute care setting. By combining proprietary, portable and rapidly deployable hardware with sophisticated artificial intelligence (AI) powered algorithms, the Ceribell System enables rapid diagnosis and continuous monitoring of patients with neurological conditions.